| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/19/2008 | US7332156 Methods of treating wounds using IL-23 |
| 02/19/2008 | CA2273848C Mycobacterium vaccae for down-regulation of the th2 activity of the immune system |
| 02/19/2008 | CA2205175C A polynucleotide tuberculosis vaccine |
| 02/19/2008 | CA2171699C Expression of porcine reproductive respiratory syndrome virus polypeptides in the same cell |
| 02/19/2008 | CA2121364C Vaccines for actinobacillus pleuropneumoniae |
| 02/14/2008 | WO2008019394A2 Methods for treatment and diagnosis of psychiatric disorders |
| 02/14/2008 | WO2008019379A2 Use of allogeneic effector cells and anti-cs1 antibodies for selective killing of multiple myeloma cells |
| 02/14/2008 | WO2008019378A1 Methods of treating multiple myeloma using combination therapies based on anti-cs1 antibodies |
| 02/14/2008 | WO2008019376A2 Compositions and methods using anti-cs1 antibodies to treat multiple myeloma |
| 02/14/2008 | WO2008019366A2 Methods and compositions for increased priming of t-cells through cross-presentation of exogenous antigens |
| 02/14/2008 | WO2008019326A2 Ephb3-specific antibody and uses thereof |
| 02/14/2008 | WO2008019291A2 Anti-alix antibodies and hybridomas |
| 02/14/2008 | WO2008019290A2 Human antibodies to erbb 2 |
| 02/14/2008 | WO2008019199A2 FCγRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF |
| 02/14/2008 | WO2008019144A2 Threapeutic methods for treating vascular eye disorders with dll4 antagonists |
| 02/14/2008 | WO2008019131A2 Methods and compositions for treating ige-mediated diseases |
| 02/14/2008 | WO2008019065A1 Use of 3- (4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment of mantle cell lymphomas |
| 02/14/2008 | WO2008018903A2 Proteins and polynucleotides of vibrio cholerae |
| 02/14/2008 | WO2008018641A1 Monoclonal antibodies against stromal derived factor-1 (sdf-1) |
| 02/14/2008 | WO2008018625A2 Prostate cancer related gene styk1 |
| 02/14/2008 | WO2008018472A1 Novel monoclonal antibody and use of the same |
| 02/14/2008 | WO2008018411A1 Method for production of live smallpox vaccine |
| 02/14/2008 | WO2008017870A1 Attenuated polio viruses |
| 02/14/2008 | WO2008017859A2 Ligand for the g6b receptor on blood platelets |
| 02/14/2008 | WO2008017826A2 Immunogenic proteins of burkholderia pseudomallei and uses thereof |
| 02/14/2008 | WO2008017636A2 Genes and proteins of brachyspira hyodysenteriae and uses thereof |
| 02/14/2008 | WO2008017568A1 Plasmids with immunological action |
| 02/14/2008 | WO2008017517A1 Immunogenic peptides and their use in immune disorders |
| 02/14/2008 | WO2008017126A1 Treatment of pulmonary disease conditions |
| 02/14/2008 | WO2007145941A8 Administration of anti-cd3 antibodies in the treatment of autoimmune diseases |
| 02/14/2008 | WO2007143689A3 Compositions and methods for modulating vascular development |
| 02/14/2008 | WO2007143600A3 Sheddase inhibitors combined with cd30-binding immunotherapeutics for the treatment of cd30 positive diseases |
| 02/14/2008 | WO2007141278A3 Human binding molecules having killing activity against enterococci and staphylococcus aureus and uses thereof |
| 02/14/2008 | WO2007137149A3 Use of cathepsin k antagonists in bone production |
| 02/14/2008 | WO2007135224A3 Method for storing silica-based material, package produced with the method and use of package for packaging of silica-based products |
| 02/14/2008 | WO2007134147A3 Method of vaccinating subjects receiving immune modulating therapy |
| 02/14/2008 | WO2007089866A3 Non-coiled protective regions of pneumococcal surface proteins pspa and pspc |
| 02/14/2008 | WO2007087418A3 Composition and method for neuromuscular blockade |
| 02/14/2008 | WO2007084344A3 Compositions and methods of use for antibodies of dickkopf-1 and/or -4 |
| 02/14/2008 | WO2007067976A3 Method of using il6 antagonists with proteasome inhibitors |
| 02/14/2008 | WO2007065098A3 Polyvalent chimeric ospc vaccinogen and diagnostic antigen |
| 02/14/2008 | WO2007059715A8 Methods and proteins for the prophylactic and/or therapeutic treatment of the four serotypes of dengue virus and other flaviviruses |
| 02/14/2008 | WO2007031875A3 Modified antigen binding molecules with altered cell signaling activity |
| 02/14/2008 | WO2007010283A8 Serine beta-lactamase-like / d-ala carboxypeptidase-like protein |
| 02/14/2008 | WO2006048781A3 IgE-RETARGETING, FUNCTION-ALTERING MOLECULES (ERFAM) FOR TREATMENT OF ALLERGIC DISEASES |
| 02/14/2008 | US20080039816 Carbohydrate-Encapsulated Quantum Dots for Bilogical Imaging |
| 02/14/2008 | US20080039419 Integrin-linked kinase and its uses |
| 02/14/2008 | US20080039401 For allergy such as asthma; modulating interleukin (IL)-9 expression |
| 02/14/2008 | US20080038361 Water-Soluble Nanoparticles Stabilized with Multi-Functional Group Ligands and Method of Preparation Thereof |
| 02/14/2008 | US20080038356 Spray freeze-dried compositions |
| 02/14/2008 | US20080038354 Polymeric matrices for the controlled release of a hydrophilic bioactive agent; hydrophilic drug delivery; side effect reduction |
| 02/14/2008 | US20080038329 T-cell activating agent |
| 02/14/2008 | US20080038319 Stimulating protective antibodies against enterotoxigenic Escherichia coli; carbonated beverages |
| 02/14/2008 | US20080038309 Use of polypeptides obtained through systematic mutations of single amino acids of human and non-human Box-A of HMGB1 to prevent and/or antagonize pathologies induced by HMGB1 |
| 02/14/2008 | US20080038296 Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells |
| 02/14/2008 | US20080038295 Compositions and methods for orthopox virus vaccination |
| 02/14/2008 | US20080038294 Intranasal or inhalational administration of virosomes |
| 02/14/2008 | US20080038293 compositions provide immune response up to and including protective immunity against porcine reproductive and respiratory syndrome (PRRS) as well as reduce the severity of PRRS virus (PRRSV) and/or incidence of PRRSV |
| 02/14/2008 | US20080038291 Method to reduce the physiologic effects of drugs on mammals |
| 02/14/2008 | US20080038287 Method For Identification, Isolation and Production of Antigens to a Specific Pathogen |
| 02/14/2008 | US20080038286 Glycosylated polypeptides produced in yeast mutants and methods of use thereof |
| 02/14/2008 | US20080038285 Method for Identifying and Quantifying of Tumour-Associated |
| 02/14/2008 | US20080038284 Human Immunodeficiency Virus Vaccine |
| 02/14/2008 | US20080038283 Methods of Evaluating Efficacy of an Immune Response by Assesing Alpha-1 Integrin Expression |
| 02/14/2008 | US20080038282 Biotinylated MHC complexes and their uses |
| 02/14/2008 | US20080038281 Model membrane systems |
| 02/14/2008 | US20080038280 A32 Monoclonal Antibody Fusion Proteins For Use As Hiv Inhibitors And Vaccines |
| 02/14/2008 | US20080038279 Composition For Treating Pathology Associated With Msrv/Herv-W |
| 02/14/2008 | US20080038278 GPAT3 encodes a mammalian, microsomal acyl-coa:glycerol 3- phosphate acyltransferase |
| 02/14/2008 | US20080038277 Dna Pkinase Inhibitors For Treating Cancer And Diabetes |
| 02/14/2008 | US20080038276 carbamimidoyl benzylamide derivatives; preventing and treating the formation of thrombin during or after a PK dependent disease or condition after fibrinolysis treatment |
| 02/14/2008 | US20080038275 Method for the treatment of multiple sclerosis |
| 02/14/2008 | US20080038274 Inhibition of secretion from non-neuronal cells |
| 02/14/2008 | US20080038273 Preventing CD28 binding to B7 by monovalent fragments antibody called CD28.3 of which exhibit sufficient affinity for the antigen so that they can be used, in vitro or in vivo, to block the CD28 receptor without activation of this receptor; autoimmune diseases; transplant rejection |
| 02/14/2008 | US20080038272 binds highly specifically and/or selectively to human receptors of the Frizzled family; hybridoma cell that produces the antibody |
| 02/14/2008 | US20080038271 Extending survival of cancer patients with elevated levels of EGF or TGF-alpha |
| 02/14/2008 | US20080038270 Antibody Specific For A Chondroitin Sulphate Epitope |
| 02/14/2008 | US20080038269 Methods for detecting and treating kidney disease |
| 02/14/2008 | US20080038268 Streptococcus Pyogenes Antigens |
| 02/14/2008 | US20080038267 Treatment Of Cancer |
| 02/14/2008 | US20080038266 Antibody or antigen binding fragment that binds acetyl-coA-acetyltransferase of Clostridium difficile |
| 02/14/2008 | US20080038265 Antibodies to Erythropoietin Receptor and Uses Thereof |
| 02/14/2008 | US20080038264 Compositions and methods for the treatment of immune related diseases |
| 02/14/2008 | US20080038263 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of mantle cell lymphomas |
| 02/14/2008 | US20080038262 Using immunoglobulin specific to shiga-like toxin as therapeutic tool in treatment and prevention of enterohemorrhagic escherichia infection |
| 02/14/2008 | US20080038261 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
| 02/14/2008 | US20080038260 specifically bind to monocyte-derived dendritic cells (MDDC); immunostimulants; downmodulating transplant rejection; cancer |
| 02/14/2008 | US20080038259 LFA-1 alpaha subunit antibodies and methods of use |
| 02/14/2008 | US20080038258 Polypeptides with Reduced Susceptibility to Oxidation and Methods of Making |
| 02/14/2008 | US20080038257 Hepatocyte growth factor (hgf) binding proteins |
| 02/14/2008 | US20080038256 having the equal or greater binding activity than that of the parent antibody with reduced immunogenicity in human; HGF/SF (hepatocyte growth factor/scatter factor); cancer |
| 02/14/2008 | US20080038255 Splice Variant of Unc5h2 |
| 02/14/2008 | US20080038254 Monoclonal antibody secific to lymphocyte peripheral membrane protein for treating and preventing transplant rejection, blood, skin, autoimmune, allergic and diabetic disorders |
| 02/14/2008 | US20080038253 Methods For Altering T Cell Diversity |
| 02/14/2008 | US20080038252 Histamine-Containing Composition for the Treatment of Allergic Diseases |
| 02/14/2008 | US20080038250 Profilin and related immunomodulatory ligands |
| 02/14/2008 | US20080038249 Treatment Of Neurodegenerative Diseases By The Use Of Laptm4a |
| 02/14/2008 | US20080038248 Proteins Ligands For Nkg2d And Ul16 Receptors And Uses Thereof |
| 02/14/2008 | US20080038247 Diagnostics and Therapeutics for Diseases Associated With G-Protein-Coupled Receptor Gpr39 (Gpr39) |
| 02/14/2008 | US20080038223 WSX-1/P28 as a target for anti-inflammatory responses |